MEDTECH NEWS
NMPA Approves Registration of 292 Medical Device Products in April 2024
11 05 2024In April 2024, China's National Medical Products Administration (NMPA) approved 292 medical device products, including various innovative devices such as single-use surgical instruments, advanced diagnostic kits, and therapeutic devices from notable companies like Volcano AtheroMed Inc., Integra LifeSciences, and Abbott Medical. These approvals span across domestic and imported devices, highlighting the NMPA's focus on expanding access to advanced medical technologies.
National Medical Products Administration Approves Registration of 193 Medical Devices in February 2024
13 03 2024The approval of 193 medical devices by NMPA in February 2024, including advanced Class III and Class II equipment, marks a significant advancement in healthcare technology, catering to diverse medical needs and enhancing patient care.
Disposable Heart Pulse Field Ablation Catheter Approved for Market Launch
12 03 2024In March 2024, the National Medical Products Administration approved Hangzhou Dinova's registration application for the innovative "Disposable Heart Pulse Field Ablation Catheter." This catheter, utilized with the company's ablation instrument, delivers targeted pulse field energy to induce precise, irreversible damage to myocardial cells, effectively treating various forms of atrial fibrillation. The product offers expanded treatment options for drug-resistant and recurrent cases, marking a significant advancement in cardiac care.
Aveir Leadless Pacemaker VR by Abbott Medical Receives Important Regulatory Approval
05 03 2024Abbott Medical's Aveir Leadless Pacemaker VR, designed for patients with severe bradycardia and offering MRI safety and rate-adaptive pacing, has received regulatory approval following extensive clinical and safety evaluations.
Breakthrough in Obesity Treatment: Gastric Bypass Stent System NMPA Review Unveiled
02 02 2024A landmark clinical trial for an innovative medical device has shown significant weight loss in subjects, underscoring a commitment to advancing non-surgical obesity treatments and medical technology innovation.
Hangzhou Tangji Medical Technology Pioneers with NMPA-Approved Gastric Bypass Stent System
31 01 2024The NMPA's approval of Hangzhou Tangji Medical Technology's innovative Gastric Bypass Stent System introduces a non-surgical obesity management solution, promising a safer alternative for effective weight loss.